Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Many Are Escaping Iran, and 'Hundreds Have Come to Faith in Jesus Christ' in the Process

Netanyahu: 'No Law' Will Pass in Knesset That 'Harms Christianity'

COVID in the 2030s: How Endless Booster Shots Will Devastate the Health of Our Children

Federal Agency Contradicts Biden, Says Student Loan Cancellation Not in Effect

Daily Signal Exclusive: GOP Bill Would Make Abortionists Report Victims of Trafficking

Is This the Bombshell Evidence That Destroyed Bragg's Case against Trump?

Trans-'Woman' (Biological Male) Finishes in First Place at New York City Women's Cycling Event, Sparks Anger

Ugandan Parliament Passes 'Anti-Homosexuality Bill,' Infuriating the Pro-LGBT West

'Cusp of Great Spiritual Awakening': Pastors Report Fresh 'Fire' in Wake of Methodist Mass Exodus

Ohio's Proposed New Abortion Amendment Will Take the State Back to the 'Dark Ages', Say Faith Leaders (VIDEO)

Supreme Court Vacates Ruling that Minors Have Constitutional 'Right' to Abortion; One Justice Dissents

NJ Mom Treated Like a Terrorist Threat, 'Demonized' for Questioning Sexual Posters in Elementary School

Wyoming Bans Gender-Confused Male Students from Competing in Girls' Sports—However...

Missouri Issues Emergency Rule Restricting 'Inhumane Science Experiments' on Children

Warning: California Bill Threatening to Remove Children from Parents over Trans Issue Passes First Committee

Famed Biologist Richard Dawkins Affirms There Are Only 2 Sexes, It's Science: 'It's Incontrovertible. There's No Scientific Doubt About This'

Give Him 15: A Deluge Is Coming

'I Just Want to Feel Like Myself,' Tearfully Admits America's Most Famous 'Trans Kid' Jazz Jennings

Franklin Graham Praises DeSantis for Drag Show Kid Crackdown: 'Doesn't Mess Around'

Biden Vetoes Bipartisan Joint Resolution That Would've Kept Woke ESG Politics Out of Retirement Plan Profits